RE:RE:RE:RE:RE:why it is very risky to invest?Consequently, on December 10, 2019, the FDA voted against approval of the NDA. On this news, Correvio shares fell 67% to close at $0.46 per share. The stock continues to decline.
Read more at https://stockhouse.com/news/press-releases/2019/12/16/shareholder-alert-robbins-llp-announces-correvio-pharma-corp-corv-sued-for#uwbH00Q4hDgAIVIw.99
These lawyers are lying, the FDA hasn't yet officially rejected the application, only the AdCom, and the longer it keeps silent the better chances of some kind of a conditional approval, because they can reject it already today and not wait until Dec.24, ha